MNPR
NASDAQ · Biotechnology
Monopar Therapeutics Inc
$119.23
+0.77 (+0.65%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
-65.4% upside
Low Target
$22.89
Average Target
$41.31
High Target
$45.20
Current Price
$119.23
Current
$119.23
$119.23
Target
$41.31
$41.31
$22.89
$41.31 avg
$45.20
Scenario Analysis
Bear Case
$22.89
-80.8%
Low target
Base Case
$41.31
-65.4%
Avg target
Bull Case
$45.20
+-62.1%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$124.82
-4.5% from high
52-Week Low
$29.18
+308.6% from low
Target vs 52W High
$41.31
-66.9% vs high
Next Earnings Report
Aug 10, 2026
1d
tomorrow
EPS Est: $-0.63
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |